The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Status Terminated

Clinical Trial Summary

This study aims to investigate the effect of abobotulinum toxin A on the symptoms of Raynaud's phenomenon.

Clinical Trial Description

This prospective double-blind randomized control trial seeks to compare a single formulation of BoNT, aboboutlinum toxin A (Dysport), to a placebo saline group, studying the effect of BoNT on Raynaud's symptoms among a more diverse population to provide insight into the patients most likely to benefit from BoNT. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03639766
Study type	Interventional
Source	University of Central Florida
Contact
Status	Terminated
Phase	Phase 4
Start date	August 31, 2018
Completion date	January 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03393325` - Tadalafil-Delivra and Raynaud's Phenomenon
Recruiting	`NCT03749577` - Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon	N/A
Completed	`NCT03699436` - Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon	N/A
Enrolling by invitation	`NCT06291142` - Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
Recruiting	`NCT03984422` - Application for Monitoring and Evaluation of Raynaud's Phenomenon
Recruiting	`NCT04015193` - Follow-up of SPTS in Patients With Raynaud's Phenomenon
Not yet recruiting	`NCT03972566` - Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
Completed	`NCT04854850` - Apollo Device for Fatigue in Systemic Sclerosis	N/A
Completed	`NCT03129178` - Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon	N/A
Completed	`NCT04388176` - Cold Challenge With C21 in RP	Phase 2
Completed	`NCT01280266` - Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon	Phase 2/Phase 3
Completed	`NCT04644523` - Dermoscopy in Primary Raynaud's Phenomenon
Completed	`NCT03094910` - Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon	N/A
Recruiting	`NCT05204784` - Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis	N/A
Recruiting	`NCT05125029` - Botulinum Toxin in Raynaud's Phenomenon	Phase 4
Withdrawn	`NCT04898036` - Phototherapy For Treatment Of Raynaud's Phenomenon	N/A
Terminated	`NCT03869008` - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.	N/A
Recruiting	`NCT01347008` - Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis	Phase 3